BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

MAPK1

MOLECULAR TARGET

mitogen-activated protein kinase 1

UniProt: P28482NCBI Gene: 5594176 compounds

MAPK1 (mitogen-activated protein kinase 1) is targeted by 176 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MAPK1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1tretinoin5.16174
2seliciclib4.91135
3caffeic acid phenethyl ester4.2569
4benzbromarone4.1361
5doramapimod4.0657
6zafirlukast3.8948
7olomoucine3.7140
8isotretinoin3.6638
9dicumarol3.5634
10meclofenamic acid3.5032
11tae 6843.4330
12iodotubercidin3.3026
13mirdametinib3.1823
14pf 037583093.0019
15hymenialdisine3.0019
16bithionol2.8917
17pf 005622712.7715
18nalfurafine2.7715
196 benzylaminopurine2.7715
20closantel2.7114
21tivozanib2.6413
22plumbagin [Supplementary Concept]2.5612
23debromohymenialdisine2.5612
24ulixertinib2.5612
25bay 2932.4811
26aceclofenac2.4811
27aloisine a2.4010
28exisulind2.309
29iodoquinol2.208
30sb 2200252.208
31ravoxertinib2.087
32pd980591.956
33tanzisertib1.956
34tribromsalan1.956
353345 tetrachlorosalicylanilide1.956
36tyrphostin ag 14781.795
37alsterpaullone1.393
38kenpaullone1.393
39Clotrimazole1.102
40sp6001251.102
41achyranthes bidentata1.001
42agastache rugosa1.001
43Garlic1.001
44allium tuberosum1.001
45aloe vera1.001
46anemarrhena asphodeloides1.001
47apis mellifera1.001
48arctium lappa1.001
49Areca1.001
50artemisia argyi1.001

Showing top 50 of 176 compounds. Use the BiohacksAI search to explore all MAPK1 modulators.

About MAPK1 as a Drug Target

MAPK1 (mitogen-activated protein kinase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 176 compounds with documented MAPK1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MAPK1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.